Investor Relations · NYSE: TRIO
Share information
TriOptimum’s common stock has been listed on the New York Stock Exchange since 1967. Prices on this page are delayed closing prices for information only.
NYSE: TRIO USD
61.84
down −0.47 (−0.75%)
Close, 2 November 2026, 4:00 p.m. EST. Delayed data, for information only.
- Exchange
- New York Stock Exchange
- Ticker
- TRIO
- CUSIP
- 89628R105
- ISIN
- US89628R1059
- Shares outstanding
- 1,214,306,512at 30 June 2026
- Market capitalisation
- $75.1 billionat close, 2 November 2026
- Transfer agent
- Harrowgate Shareholder Services
- Fiscal year end
- 31 December
Dividends
| Declared | Ex-dividend | Paid | Amount |
|---|---|---|---|
| 2026-09-24 | 2026-10-09 | 2026-11-06 | $0.52 |
| 2026-06-25 | 2026-07-10 | 2026-08-07 | $0.52 |
| 2026-03-26 | 2026-04-10 | 2026-05-08 | $0.52 |
| 2025-12-11 | 2026-01-09 | 2026-02-06 | $0.52 |
TriOptimum has paid a dividend every year since 1967 and has increased it in 41 of the last 45 years. The dividend payable on 6 November 2026 was declared on 24 September 2026. The next declaration is expected in December.
Dividends are declared at the discretion of the Board. Registered shareholders can have dividends paid directly to a bank account or reinvested through the transfer agent’s dividend reinvestment plan.
Monthly closing prices
| Month | Last trading day | Close |
|---|---|---|
| November 2026 | 2026-11-02 | 61.84 |
| October 2026 | 2026-10-30 | 62.31 |
| September 2026 | 2026-09-30 | 79.76 |
| August 2026 | 2026-08-31 | 81.60 |
| July 2026 | 2026-07-31 | 83.40 |
| June 2026 | 2026-06-30 | 79.14 |
| May 2026 | 2026-05-29 | 79.57 |
| April 2026 | 2026-04-30 | 77.63 |
| March 2026 | 2026-03-31 | 76.47 |
| February 2026 | 2026-02-27 | 76.05 |
| January 2026 | 2026-01-30 | 75.08 |
| December 2025 | 2025-12-31 | 73.24 |
| November 2025 | 2025-11-28 | 71.80 |
Analyst coverage
TriOptimum is covered by 17 sell-side analysts. Their opinions, estimates and forecasts are their own and do not represent those of TriOptimum or its management. TriOptimum does not publish consensus estimates or endorse any analyst’s work. A list of covering firms is available from Investor Relations.